These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38980253)

  • 1. An immune biomarker associated with EMT serves as a predictor for prognosis and drug response in bladder cancer.
    Jiang Y; Yu Z; Zheng H; Zhou X; Zhou M; Geng X; Zhu Y; Huang S; Gong Y; Guo L
    Aging (Albany NY); 2024 Jul; 16(13):10813-10831. PubMed ID: 38980253
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Song DM; Shen T; Feng K; He YB; Chen SL; Zhang Y; Luo WF; Han L; Tong M; Jin Y
    Front Immunol; 2024; 15():1419126. PubMed ID: 39234248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a tumor microenvironment-related seven-gene signature for predicting prognosis in bladder cancer.
    Wang Z; Tu L; Chen M; Tong S
    BMC Cancer; 2021 Jun; 21(1):692. PubMed ID: 34112144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor stemness score to estimate epithelial-to-mesenchymal transition (EMT) and cancer stem cells (CSCs) characterization and to predict the prognosis and immunotherapy response in bladder urothelial carcinoma.
    Zhang Y; Zhang X; Huang X; Tang X; Zhang M; Li Z; Hu X; Zhang M; Wang X; Yan Y
    Stem Cell Res Ther; 2023 Feb; 14(1):15. PubMed ID: 36721217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer.
    Chi M; Liu J; Mei C; Shi Y; Liu N; Jiang X; Liu C; Xue N; Hong H; Xie J; Sun X; Yin B; Meng X; Wang B
    J Exp Clin Cancer Res; 2022 May; 41(1):175. PubMed ID: 35581606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance and immunoinfiltration analysis of genes associated with epithelial-mesenchymal transition and energy metabolism in bladder urothelial carcinoma.
    Qiu Y; Ye W; Wang C; Zang J
    Aging (Albany NY); 2023 Nov; 15(22):13312-13328. PubMed ID: 38015710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple omics integrative analysis identifies GARS1 as a novel prognostic and immunological biomarker: from pan-cancer to bladder cancer.
    Liu W; Wei C; He Q; Chen Z; Zhuang W; Guo Y; Xue X
    Sci Rep; 2024 Aug; 14(1):19025. PubMed ID: 39152248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An EMT-related gene signature for the prognosis of human bladder cancer.
    Cao R; Yuan L; Ma B; Wang G; Qiu W; Tian Y
    J Cell Mol Med; 2020 Jan; 24(1):605-617. PubMed ID: 31657881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wnt pathway-related three-mRNA clinical outcome signature in bladder urothelial carcinoma: computational biology and experimental analyses.
    Sun S; Wang Y; Wang J; Bi J
    J Transl Med; 2021 Sep; 19(1):409. PubMed ID: 34579753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FGL2 as a predictive biomarker for prognosis and immunotherapy in bladder cancer.
    Huang Z; Wang Z; Xu C; Yan Y; Cao X; Zhang F; Shen B
    Int J Med Sci; 2024; 21(8):1447-1460. PubMed ID: 38903931
    [No Abstract]   [Full Text] [Related]  

  • 11. A co-expression network for differentially expressed genes in bladder cancer and a risk score model for predicting survival.
    Chen Z; Liu G; Hossain A; Danilova IG; Bolkov MA; Liu G; Tuzankina IA; Tan W
    Hereditas; 2019; 156():24. PubMed ID: 31333338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. JAM3: A prognostic biomarker for bladder cancer via epithelial-mesenchymal transition regulation.
    Pang ZQ; Wang JS; Wang JF; Wang YX; Ji B; Xu YD; He JX; Zhang L; Zhang LQ; Ding BC; Liu Y; Ren MH
    Biomol Biomed; 2024 Feb; 24(4):897-911. PubMed ID: 38400838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a prognostic index and screening of prognosis related genes based on an immunogenomic landscape analysis of bladder cancer.
    Qu G; Liu Z; Yang G; Xu Y; Xiang M; Tang C
    Aging (Albany NY); 2021 Apr; 13(8):12099-12112. PubMed ID: 33888644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical significance of transcription factor WD repeat and HMG-box DNA binding protein 1 in laryngeal squamous cell carcinoma and its potential molecular mechanism.
    Wu JY; Lan XL; Yan DM; Fang YY; Peng YX; Liang FF; Jiang L; Huang SN; Mo M; Lin CX; Niu YT; Wu XW; Wei ZX
    Pathol Res Pract; 2022 Feb; 230():153751. PubMed ID: 34999279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel signature constructed by mitochondrial function and cell death-related gene for the prediction of prognosis in bladder cancer.
    Yan Z; Liu Y; Wang M; Wang L; Chen Z; Liu X
    Sci Rep; 2024 Jun; 14(1):14667. PubMed ID: 38918587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel TGF-β Risk Score Predicts the Clinical Outcomes and Tumour Microenvironment Phenotypes in Bladder Cancer.
    Liu Z; Qi T; Li X; Yao Y; Othmane B; Chen J; Zu X; Ou Z; Hu J
    Front Immunol; 2021; 12():791924. PubMed ID: 34975891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and validation of sialyltransferase ST3Gal5 in bladder cancer through bioinformatics and experimental analysis.
    Jian Y; Chen Q; Al-Danakh A; Xu Z; Xu C; Sun X; Yu X; Yang D; Wang S
    Int Immunopharmacol; 2024 Sep; 138():112569. PubMed ID: 38959540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basement membrane-related MMP14 predicts poor prognosis and response to immunotherapy in bladder cancer.
    Zhang X; Hong B; Li H; Zhao J; Li M; Wei D; Wang Y; Zhang N
    BMC Cancer; 2024 Jun; 24(1):746. PubMed ID: 38898429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA-Sequencing Data Reveal a Prognostic Four-lncRNA-Based Risk Score for Bladder Urothelial Carcinoma: An in Silico Update.
    He RQ; Huang ZG; Li TY; Wei YP; Chen G; Lin XG; Wang QY
    Cell Physiol Biochem; 2018; 50(4):1474-1495. PubMed ID: 30359990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a Prognosis-Related Risk Signature for Bladder Cancer to Predict Survival and Immune Landscapes.
    Wang L; Wang Y; Wang J; Li L; Bi J
    J Immunol Res; 2021; 2021():3236384. PubMed ID: 34708131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.